Low-molecular-weight heparin versus aspirin for acute ischemic stroke with large artery occlusive disease: Subgroup analyses from the fraxiparin in stroke study for the treatment of ischemic stroke (FISS-tris) study

Stroke

Volumn 43, Issue 2, 2012, Pages 346-349

  Wang, Qiao Shu ^a   Chen, Christopher ^b   Chen, Xiang Yan ^c   Han, Jing Hao ^c   Soo, Yannie ^c   Leung, Thomas W ^c   Mok, Vincent ^c   Wong, Ka Sing Lawrence ^c  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

acute stroke; anticoagulation; heparin; intracranial stenosis; ischemia

Indexed keywords

ACETYLSALICYLIC ACID; NADROPARIN;

ADULT; AGED; ARTICLE; BARTHEL INDEX; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTERNAL CAROTID ARTERY OCCLUSION; LARGE ARTERY OCCLUSIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MULTICENTER STUDY; OCCLUSIVE CEREBROVASCULAR DISEASE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFIBRINOLYTIC AGENTS; ARTERIAL OCCLUSIVE DISEASES; ASPIRIN; BRAIN ISCHEMIA; FEMALE; HONG KONG; HUMANS; INTRACRANIAL ARTERIAL DISEASES; MALE; MIDDLE AGED; NADROPARIN; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; SINGAPORE; STROKE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84856440263     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.628347     Document Type: Article

References (26)

1. Wong KS, Chen C, Ng PW, Tsoi TH, Li HL, Fong WC, et al. Lowmolecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: A randomised study. Lancet Neurol. 2007;6:407-413. (Pubitemid 46551851)
2. Low molecular weight heparinoid, Org 10172 (danaparoid), and outcome after acute ischemic stroke: A randomized controlled trial. The publications committee for the Trial of Org 10172 in Acute Stroke Treatment (TOAST) investigators. JAMA. 1998;279:1265-1272.
3. Chimowitz MI, Kokkinos J, Strong J, Brown MB, Levine SR, Silliman S, et al. The Warfarin-Aspirin Symptomatic Intracranial Disease study. Neurology. 1995;45:1488-1493.
4. Kasner SE, Lynn MJ, Chimowitz MI, Frankel MR, Howlett-Smith H, Hertzberg VS, et al. Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID. Neurology. 2006;67:1275-1278. (Pubitemid 44563843)
5. Qureshi AI, Ziai WC, Yahia AM, Mohammad Y, Sen S, Agarwal P, et al. Stroke-free survival and its determinants in patients with symptomatic vertebrobasilar stenosis: A multicenter study. Neurosurgery. 2003;52: 1033-1039; discussion 1039-1040.
6. Caplan LR, Gorelick PB, Hier DB. Race, sex and occlusive cerebrovascular disease: A review. Stroke. 1986;17:648-655. (Pubitemid 16066533)
7. Kuller L, Reisler DM. An explanation for variations in distribution of stroke and arteriosclerotic heart disease among populations and racial groups. Am J Epidemiol. 1971;93:1-9.
8. Sacco RL, Kargman DE, Gu Q, Zamanillo MC. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke. 1995;26:14-20.
9. Gorelick PB, Caplan LR, Hier DB, Parker SL, Patel D. Racial differences in the distribution of anterior circulation occlusive disease. Neurology. 1984;34:54-59. (Pubitemid 14220912)
10. Wong KS, Li H, Chan YL, Ahuja A, Lam WW, Wong A, et al. Use of transcranial Doppler ultrasound to predict outcome in patients with intracranial large-artery occlusive disease. Stroke. 2000;31:2641-2647.
11. Wong KS, Lam WW, Liang E, Huang YN, Chan YL, Kay R. Variability of magnetic resonance angiography and computed tomography angiography in grading middle cerebral artery stenosis. Stroke. 1996;27: 1084-1087. (Pubitemid 26177610)
12. Duncan PW, Samsa GP, Weinberger M, Goldstein LB, Bonito A, Witter DM, et al. Health status of individuals with mild stroke. Stroke. 1997; 28:740-745. (Pubitemid 27161456)
13. Gorelick PB, Wong KS, Bae HJ, Pandey DK. Large artery intracranial occlusive disease: A large worldwide burden but a relatively neglected frontier. Stroke. 2008;39:2396-2399.
14. Bae HJ, Lee J, Park JM, Kwon O, Koo JS, Kim BK, et al. Risk factors of intracranial cerebral atherosclerosis among asymptomatics. Cerebrovasc Dis. 2007;24:355-360. (Pubitemid 47482041)
15. Thijs VN, Albers GW. Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Neurology. 2000;55: 490-497. (Pubitemid 30647243)
16. Park KY, Chung CS, Lee KH, Kim GM, Kim YB, Oh K. Prevalence and risk factors of intracranial atherosclerosis in an asymptomatic Korean population. J Clin Neurol. 2006;2:29-33.
17. Solberg LA, McGarry PA. Cerebral atherosclerosis in Negroes and Caucasians. Atherosclerosis. 1972;16:141-154.
18. Turan TN, Makki AA, Tsappidi S, Cotsonis G, Lynn MJ, Cloft HJ, et al. Risk factors associated with severity and location of intracranial arterial stenosis. Stroke. 2010;41:1636-1640.
19. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352:1305-1316.
20. Heyden S, Heyman A, Goree JA. Nonembolic occlusion of the middle cerebral and carotid arteries-a comparison of predisposing factors. Stroke. 1970;1:363-369.
21. Wong KS, Ng PW, Tang A, Liu R, Yeung V, Tomlinson B. Prevalence of asymptomatic intracranial atherosclerosis in high-risk patients. Neurology. 2007;68:2035-2038. (Pubitemid 46869710)
22. Wong KS, Huang YN, Yang HB, Gao S, Li H, Liu JY, et al. A doorto-door survey of intracranial atherosclerosis in Liangbei County, China. Neurology. 2007;68:2031-2034. (Pubitemid 46869709)
23. Khan U, Porteous L, Hassan A, Markus HS. Risk factor profile of cerebral small vessel disease and its subtypes. J Neurol Neurosurg Psychiatry. 2007;78:702-706. (Pubitemid 46998839)
24. Perneger TV. What's wrong with Bonferroni adjustments. BMJ. 1998; 316:1236-1238. (Pubitemid 28171344)
25. Mazighi M, Tanasescu R, Ducrocq X, Vicaut E, Bracard S, Houdart E, et al. Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study. Neurology. 2006;66:1187-1191. (Pubitemid 43739702)
26. Lovett JK, Coull AJ, Rothwell PM. Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology. 2004; 62:569-573. (Pubitemid 38252797)